Physician

Allyson Tracy Tevrizian, MD

According to 2025 Medicare claims, Allyson Tevrizian, MD (NPI: 1902930753) practices allergy/immunology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is ALLERGY & ASTHMA MEDICAL GROUP OF THE BAY AREA INC (NPI: 1871550590; TIN: 94-2437825) and primary practice location at 94588-9998.

Tevrizian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 196 traditional Medicare patients, billed 48,879 HCPCS/CPT codes, and received $920,154 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,075 prescription claims across 207 beneficiaries totaling $371,605 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 92 claims. Open Payments data shows 89 records totaling $11,898. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $139,823 to $920,154. Similarly, Part D prescription costs have moved sharply higher in recent years, from $113,717 to $371,605. In contrast, DME billing represents a smaller volume and rose steadily, from $692 to $1,769.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	111	6,731	$139,823
2016	114	10,914	$273,513
2017	134	28,081	$471,187
2018	153	36,184	$597,579
2019	155	29,429	$509,031
2020	150	30,012	$499,616
2021	181	27,646	$507,845
2022	180	28,904	$630,503
2023	183	47,244	$906,056
2024	196	48,879	$920,154

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	98	733	$113,717
2016	120	838	$132,629
2017	140	911	$161,874
2018	136	1,022	$187,456
2019	149	911	$171,946
2020	152	728	$154,420
2021	161	907	$236,165
2022	170	866	$337,498
2023	171	981	$420,028
2024	207	1,075	$371,605

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	30	$3,454
2017	13	49	$4,441
2018	11	88	$21,542
2019	13	102	$115,181
2020	N/R	61	$97,816
2021	N/R	27	$99,777
2022	N/R	41	$108,811
2023	11	140	$137,473
2024	N/R	92	$150,618

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	84	141	$112
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	130	$81
94010	Test to measure expiratory airflow and volume	83	129	$27
95012	Test to measure the level of nitric oxide gas	84	136	$20
96160	Administration and interpretation of patient-focused health risk assessment	89	167	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	27	756	$103,655
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	2,190	$41,556
Breo Ellipta	Fluticasone/Vilanterol	54	1,800	$22,635
Advair Hfa	Fluticasone Propion/Salmeterol	27	1,545	$19,937
Epinephrine	Epinephrine	35	470	$6,021

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	13	$122,258
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	13	$25,470
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	18	$1,276
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	22	$1,173
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	13	$308

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	88	$11,898	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$4,891	Consortium of Independent Immunology Clinics, LLC

Explore More Providers

FAQ

What Medicare data is available for Allyson Tracy Tevrizian, MD?

Tedicare shows public-source Medicare data for Allyson Tracy Tevrizian, MD (NPI 1902930753), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allyson Tracy Tevrizian, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Allyson Tracy Tevrizian, MD?

Allyson Tracy Tevrizian, MD is linked to ALLERGY & ASTHMA MEDICAL GROUP OF THE BAY AREA INC (billing NPI 1871550590) in the available physician profile data.

Does Allyson Tracy Tevrizian, MD have Open Payments data?

Allyson Tracy Tevrizian, MD has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.